BRUKINSA
Identification of Brukinsa
| No description |
Google image searchProduct monograph
Active ingredient
zanubrutinib, 80 MG
DIN: 02512963
Dosage form(s): CAPSULE
Route(s) of administration: ORAL
Schedule: Prescription
Company: BEIGENE SWITZERLAND GMBH
Date: 30-MAR-2021
ATC:
- L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
- L01E — PROTEIN KINASE INHIBITORS (ATC, ATC/DDD)
- L01EL — Bruton's tyrosine kinase (BTK) inhibitors (ATC, ATC/DDD)
- L01EL03 — ZANUBRUTINIB (ATC/DDD)
Reference brand drug: Brukinsa
